hPL (ABT223) PathoELITE™ Mouse mAb

Assay Biotechnology Inc Antibodies and ELISA Kits have been rigorously validated for laboratory grade quality results. High specificity paired with high affinity for targets of interest give researchers an advantage with our products

Catalog No: YM6139

Reactivity:Human

Applications:Immunohistochemistry (IHC)

Modification:Not Modified

Source:Mouse

Storage and Stability:Store at -20°C/1 year

Size:

Price/Quantity $95

Quantity:

Datasheet

Pathology Grade Abs

hPL (ABT223) PathoELITE™ Mouse mAb

Human placenta tissue was stained with anti-hPL (ABT223) Antibody

Delivery

Freight Charges

Utilize our shipping calculator at checkout to view

Lead Time

Antibodies 1-2 business day, ELISA kits 2-3 business day lead time

Telephone

408-747-0185

Fax

408-747-0145

order@assaybiotech.com

Promotions

Product Details

Product Name

hPL (ABT223) PathoELITE™ Mouse mAb

Description

Human placental prolactin (HPL) is a 22 kD polypeptide hormone synthesized and secreted by placental syncytiotrophoblast cells, has partial homology with growth hormone. It is expressed in normal placenta, choriocarcinoma, testicular cancer. Anti-HPL antibody is commonly used in the study of trophoblastic tumors.

Catalog No

YM6139

Reactivity

Human

Source

Mouse

Modification

Not Modified

Applications

Immunohistochemistry (IHC)

Dilution

IHC 1:200-400, IF 1:50-200, ELISA, 1:500-5000

Purification

The antibody was purified by affinity chromatography using a specific immunogen.

Storage and Stability

P0DML2;P0DML3;

Human Swiss Prot No.

SST

Gene Name

Somatostatin

Protein Name

6750

Gene ID

Growth hormone release inhibiting factor,Growth hormone release-inhibiting factor,Prepro somatostatin,SMS_HUMAN,SMST,Somatostatin 14,Somatostatin 28,Somatostatin-14,SST

Other Name

The antibody can recognize human Placental lactogen with no cross-reactiin with GH protein.

Specificity

The antibody is provided in liquid form in phosphate-buffered saline with 50% glycerol, 0.05% BSA, and 0.05% Proclin 300.

Formulation